• Users Online: 1656
  • Print this page
  • Email this page

  Download for Citation Managers


Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of a Phase III randomized trial to compare the benefit of gefitinib versus pemetrexed/carboplatin for epidermal growth factor receptor-mutated non-small cell lung cancer
Patil Vijay, Noronha Vanita, Joshi Amit, Chougule Anuradha, Bhattacharjee Atanu, Goel Alok, Talreja Vikas, Menon Nandini, Ramaswamy Anant, Karpe Ashay, Pande Nikhil, Chandrasekharan Arun, Mahajan Abhishek, Janu Amit, Purandare Nilendu, Prabhash Kumar

Year : 2019 | Volume:  2 | Issue Number:  1 | Page: 21-27

Click here to read this article

Select type of program  for download
EndNote format (Mac & Win)
- Download
Reference Manager
Ris format (Win only)
- Download
Ris format (Win only)
- Download
Medlars Format - Download
RefWorks Format
RefWorks format (Mac & Win)
- Download
BibTex Format
BibTex format (Mac & Win)
- Download